Nasdaq-listed Agape Unveils Flagship Wellness Product

Nasdaq-listed Agape ATP Corporation's (ATPC) subsidiary Agape Superior Living Sdn Bhd (ASL) has unveiled the enhanced version of its wellness flagship supplement, ATP2.

ATPV said it is designed to address key health challenges including ageing, metabolism, and chronic disease management.

The company aims to sell 5,000 units by year-end.

ATP2 plays a critical role in managing blood pressure and blood sugar levels, promoting cardiovascular health and improving gut flora, said ATPC founder and global group chief executive officer Prof Datuk Seri Dr How Kok Choong.

he product's anti-aging properties come from its ability to enhance cellular repair, reduce oxidative stress, and stabilise genome function, helping users maintain a youthful, energetic state as they age,, he added.

The product is locally manufactured in Malaysia, while its formulation incorporates advanced technologies from Australia, the United States, Europe and Japan.